Ftse Mib
34.374,06
-0,01%
DAX
18.511,02
-0,48%
S&P 500
5.651,64
0,36%
NASDAQ
18.439,91
-0,18%
Bitcoin
63.643,84
-1,88%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Regno Unito LSE Evgen Pharma Plc (EVG) Evgen Pharma Plc (EVG) Notizie

EVG

Evgen Pharma (EVG)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG
DataOraFonteTitoloSimboloCompagnia
08/11/201808:01UK RegulatoryEvgen Pharma PLC Directorate ChangesLSE:EVGEvgen Pharma Plc
23/10/201813:55Alliance NewsAlliance NewsDavid And Monique Newlands Build 5% Stake In Evgen Pharma (ALLISS)LSE:EVGEvgen Pharma Plc
23/10/201810:57UK RegulatoryEvgen Pharma PLC Holding(s) in CompanyLSE:EVGEvgen Pharma Plc
18/10/201811:26Alliance NewsAlliance NewsEvgen Pharma Raises GBP750,000 Via Share Placing (ALLISS)LSE:EVGEvgen Pharma Plc
18/10/201808:01UK RegulatoryEvgen Pharma PLC PlacingLSE:EVGEvgen Pharma Plc
18/09/201808:00UK RegulatoryEvgen Pharma PLC Investor SymposiumLSE:EVGEvgen Pharma Plc
11/09/201808:01UK RegulatoryEvgen Pharma PLC Notice of Investor SymposiumLSE:EVGEvgen Pharma Plc
26/07/201816:22UK RegulatoryEvgen Pharma PLC Result of AGMLSE:EVGEvgen Pharma Plc
26/07/201813:54Alliance NewsAlliance NewsEvgen Pharma Expects Final Results From Clinical Trials At End Of YearLSE:EVGEvgen Pharma Plc
26/07/201808:02UK RegulatoryEvgen Pharma PLC AGM StatementLSE:EVGEvgen Pharma Plc
25/07/201814:31Alliance NewsAlliance NewsEvgen Pharma Metastatic Breast Cancer Trial Ends Patient RecruitmentLSE:EVGEvgen Pharma Plc
25/07/201808:00UK RegulatoryEvgen Pharma PLC Final Patient Recruited in STEM Phase IIa TrialLSE:EVGEvgen Pharma Plc
10/07/201812:00UK RegulatoryEvgen Pharma PLC Grant of share options, issue of equity and TVRLSE:EVGEvgen Pharma Plc
21/06/201813:30UK RegulatoryEvgen Pharma PLC Posting of Annual Report and AGM NoticeLSE:EVGEvgen Pharma Plc
13/06/201811:46Alliance NewsAlliance NewsEvgen Pharma Annual Loss Narrows As It Continues Phase II TrialsLSE:EVGEvgen Pharma Plc
13/06/201808:00UK RegulatoryEvgen Pharma PLC Full Year ResultsLSE:EVGEvgen Pharma Plc
11/06/201812:33Alliance NewsAlliance NewsEvgen STEM Interim Trial Result Show "Signs Of Anti-Tumour Activity"LSE:EVGEvgen Pharma Plc
11/06/201810:05UK RegulatoryEvgen Pharma PLC Second Price Monitoring ExtnLSE:EVGEvgen Pharma Plc
11/06/201810:00UK RegulatoryEvgen Pharma PLC Price Monitoring ExtensionLSE:EVGEvgen Pharma Plc
11/06/201808:00UK RegulatoryEvgen Pharma PLC Interim Update on STEM TrialLSE:EVGEvgen Pharma Plc
30/05/201808:01UK RegulatoryEvgen Pharma PLC Notification of Preliminary ResultsLSE:EVGEvgen Pharma Plc
14/05/201808:00RNS Non-RegulatoryEvgen Pharma PLC Upcoming Investor PresentationsLSE:EVGEvgen Pharma Plc
02/05/201812:15Alliance NewsAlliance NewsEvgen Pharma Gets European Patent For Sulforaphane Stablising MethodLSE:EVGEvgen Pharma Plc
02/05/201808:00UK RegulatoryEvgen Pharma PLC Grant of further European patentLSE:EVGEvgen Pharma Plc
24/04/201808:00UK RegulatoryEvgen Pharma PLC Presentation at World Orphan Drug Congress USALSE:EVGEvgen Pharma Plc
20/03/201814:56Alliance NewsAlliance NewsEvgen Pharma Begins Research Partnership With Imperial College LondonLSE:EVGEvgen Pharma Plc
20/03/201808:00UK RegulatoryEvgen Pharma PLC Research Collaboration with Imperial CollegeLSE:EVGEvgen Pharma Plc
05/03/201813:02Alliance NewsAlliance NewsEvgen Pharma Receives Positive Sulforaphane Results From EvaulationLSE:EVGEvgen Pharma Plc
05/03/201808:00UK RegulatoryEvgen Pharma PLC Update on Novel Sulforaphane AnaloguesLSE:EVGEvgen Pharma Plc
15/01/201814:05Alliance NewsAlliance NewsEvgen Says SFX-01 Could Improve Endocrine Therapy For Breast CancerLSE:EVGEvgen Pharma Plc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:LSE:EVG

La tua Cronologia

TSX
CUF.UN
Cominar Real Estate Inve...
NASDAQ
CENT
Central Garden and Pet
TSXV
ZACA
Zacapa Resources
LSE
AFMC
Aberdeen Frontier Market...
LSE
SPLT
Ishs Platinum �
LSE
FLOT
Is $ Flt Rte Bd
LSE
TR3G
Iv Ust 1-3 D Gb
LSE
ISAC
Ishr Acwi
NASDAQ
CATY
Cathay General Bancorp
NASDAQ
SONO
Sonos
LSE
QLT
Quilter
LSE
0K92
Northrop Grumman
LSE
GSD
Goldshield
NASDAQ
STFC
State Auto Financial
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network